Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Feldmann M, Maini RN, Woody JN, Holgate ST, et al. Lancet 2020 Apr 9. pii: S0140-6736(20)30858.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feldmann M, Maini RN, Woody JN, Holgate ST, et al. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 2020 Apr 9. pii: S0140-6736(20)30858.
PMID: 32278362